BIOMAT Database Logo BIOMAT Database Logo

IgG heavy-chain (Gm) allotypes and immune response to insulin in insulin-requiring diabetes mellitus. 1981

Y Nakao, and H Matsumoto, and T Miyazaki, and N Mizuno, and N Arima, and A Wakisaka, and K Okimoto, and Y Akazawa, and K Tsuji, and T Fujita

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007126 Immunoglobulin Allotypes Allelic variants of the immunoglobulin light chains (IMMUNOGLOBULIN LIGHT CHAINS) or heavy chains (IMMUNOGLOBULIN HEAVY CHAINS) encoded by ALLELES of IMMUNOGLOBULIN GENES. Allotypes, Immunoglobulin,Allotypic Antibodies,Antibodies, Allotypic,Ig Allotypes,Allotype, Ig,Allotype, Immunoglobulin,Allotypes, Ig,Allotypic Antibody,Antibody, Allotypic,Ig Allotype,Immunoglobulin Allotype
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D002874 Chromosome Mapping Any method used for determining the location of and relative distances between genes on a chromosome. Gene Mapping,Linkage Mapping,Genome Mapping,Chromosome Mappings,Gene Mappings,Genome Mappings,Linkage Mappings,Mapping, Chromosome,Mapping, Gene,Mapping, Genome,Mapping, Linkage,Mappings, Chromosome,Mappings, Gene,Mappings, Genome,Mappings, Linkage
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D005802 Genes, MHC Class II Genetic loci in the vertebrate major histocompatibility complex that encode polymorphic products which control the immune response to specific antigens. The genes are found in the HLA-D region in humans and include H-2M, I-A, and I-E loci in mice. Class II Genes,Genes, Class II,Genes, HLA Class II,MHC Class II Genes,Class II Gene,Gene, Class II
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody

Related Publications

Y Nakao, and H Matsumoto, and T Miyazaki, and N Mizuno, and N Arima, and A Wakisaka, and K Okimoto, and Y Akazawa, and K Tsuji, and T Fujita
IgG heavy chain (Gm) allotypes in diabetes.
September 1981, Immunology today,
Y Nakao, and H Matsumoto, and T Miyazaki, and N Mizuno, and N Arima, and A Wakisaka, and K Okimoto, and Y Akazawa, and K Tsuji, and T Fujita
IgG heavy chain (Gm) allotypes in ankylosing spondylitis.
March 1985, Clinical rheumatology,
Y Nakao, and H Matsumoto, and T Miyazaki, and N Mizuno, and N Arima, and A Wakisaka, and K Okimoto, and Y Akazawa, and K Tsuji, and T Fujita
IgG heavy-chain (Gm) allotypes in familial polyposis coli.
July 1986, American journal of human genetics,
Y Nakao, and H Matsumoto, and T Miyazaki, and N Mizuno, and N Arima, and A Wakisaka, and K Okimoto, and Y Akazawa, and K Tsuji, and T Fujita
Lack of interaction of HLA and IgG heavy chain allotypes in insulin-dependent diabetes mellitus.
January 1989, Experimental and clinical immunogenetics,
Y Nakao, and H Matsumoto, and T Miyazaki, and N Mizuno, and N Arima, and A Wakisaka, and K Okimoto, and Y Akazawa, and K Tsuji, and T Fujita
Conformational dependency of human IgG heavy chain-associated Gm allotypes.
March 1993, Molecular immunology,
Y Nakao, and H Matsumoto, and T Miyazaki, and N Mizuno, and N Arima, and A Wakisaka, and K Okimoto, and Y Akazawa, and K Tsuji, and T Fujita
IgG and IgA heavy chain allotypes in Type 1 diabetes.
August 1983, Journal of immunogenetics,
Y Nakao, and H Matsumoto, and T Miyazaki, and N Mizuno, and N Arima, and A Wakisaka, and K Okimoto, and Y Akazawa, and K Tsuji, and T Fujita
Gluten-sensitive enteropathy. Immunoglobulin G heavy-chain (Gm) allotypes and the immune response to wheat gliadin.
July 1983, The Journal of clinical investigation,
Y Nakao, and H Matsumoto, and T Miyazaki, and N Mizuno, and N Arima, and A Wakisaka, and K Okimoto, and Y Akazawa, and K Tsuji, and T Fujita
Interaction of IgG heavy-chain allotypes (Gm) and HLA in conferring susceptibility to thyroid carcinoma.
July 1986, Clinical endocrinology,
Y Nakao, and H Matsumoto, and T Miyazaki, and N Mizuno, and N Arima, and A Wakisaka, and K Okimoto, and Y Akazawa, and K Tsuji, and T Fujita
The association of IgG heavy-chain allotypes (Gm) with Graves' disease in Hungary.
January 1985, Experimental and clinical immunogenetics,
Y Nakao, and H Matsumoto, and T Miyazaki, and N Mizuno, and N Arima, and A Wakisaka, and K Okimoto, and Y Akazawa, and K Tsuji, and T Fujita
IgG heavy-chain (Gm) allotypes in demyelinating polyneuropathy associated with MAG-binding monoclonal IgM autoantibodies.
May 1987, Annals of neurology,
Copied contents to your clipboard!